DOUGLAS LIND

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

Enveric Biosciences, Inc.

Filing Date Source Excerpt
2021-04-13 Douglas Lind
2022-05-31 Name Fees earned or paid in cash ($) Equity awards ($) Total ($) Douglas Lind 24,000 32,432 56,432 Consists of RSA’s equivalent to 9,059 shares of Common Stock, valued at $3.58 per share (the closing price per share on the date of the award). As of December 31, 2021, Douglas Lind had outstanding 9,059 RSA’s.

Data sourced from SEC filings. Last updated: 2026-02-03